Global Gastroparesis Drugs Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

July 2018 | 132 pages | ID: G869F42AEE8EN
GlobalInfoResearch

Abstracts

Gastroparesis also known as delayed gastric emptying, is a disorder that stops or slows the movement of food through the digestive tract.

SCOPE OF THE REPORT:

This report studies the Gastroparesis Drugs market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Gastroparesis Drugs market by product type and applications/end industries.
The idiopathic gastroparesis segment dominated the global gastroparesis drugs market during 2017 and the segment is expected to continue its dominance during the next few years as well. The market is witnessing the development of new and effective therapies for the symptomatic control of idiopathic gastroparesis, which will be one of the major factors responsible for the market segment?s growth.
The prokinetic agents segment accounted for the major shares of the gastroparesis drugs market and according to this market research and analysis, the segment will continue its market dominance during the next few years as well. Prokinetic agents are used to relieve a large number of gastrointestinal (GI) symptoms such as bloating, constipation, abdominal discomfort, vomiting, nausea, and heartburn.
The global Gastroparesis Drugs market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Gastroparesis Drugs.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

• Cadila Pharmaceuticals
• GlaxoSmithKline
• Johnson & Johnson
• Valeant
• Evoke Pharma
• Teva Pharmaceutical Industries
• Theravance Biopharma

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Prokinetic Agents
• Antiemetic Agents
• Botulinum Toxin Injection
• Other

Market Segment by Applications, can be divided into

• Diabetic Gastroparesis
• Idiopathic Gastroparesis

Contents

1 GASTROPARESIS DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Gastroparesis Drugs
1.2 Classification of Gastroparesis Drugs by Types
  1.2.1 Global Gastroparesis Drugs Revenue Comparison by Types (2017-2023)
  1.2.2 Global Gastroparesis Drugs Revenue Market Share by Types in 2017
  1.2.3 Prokinetic Agents
  1.2.4 Antiemetic Agents
  1.2.5 Botulinum Toxin Injection
  1.2.6 Other
1.3 Global Gastroparesis Drugs Market by Application
  1.3.1 Global Gastroparesis Drugs Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Diabetic Gastroparesis
  1.3.3 Idiopathic Gastroparesis
1.4 Global Gastroparesis Drugs Market by Regions
  1.4.1 Global Gastroparesis Drugs Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Gastroparesis Drugs Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Gastroparesis Drugs Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Gastroparesis Drugs Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Gastroparesis Drugs Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Gastroparesis Drugs Status and Prospect (2013-2023)
1.5 Global Market Size of Gastroparesis Drugs (2013-2023)

2 MANUFACTURERS PROFILES

2.1 Cadila Pharmaceuticals
  2.1.1 Business Overview
  2.1.2 Gastroparesis Drugs Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Cadila Pharmaceuticals Gastroparesis Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.2 GlaxoSmithKline
  2.2.1 Business Overview
  2.2.2 Gastroparesis Drugs Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 GlaxoSmithKline Gastroparesis Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.3 Johnson & Johnson
  2.3.1 Business Overview
  2.3.2 Gastroparesis Drugs Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Johnson & Johnson Gastroparesis Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.4 Valeant
  2.4.1 Business Overview
  2.4.2 Gastroparesis Drugs Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Valeant Gastroparesis Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.5 Evoke Pharma
  2.5.1 Business Overview
  2.5.2 Gastroparesis Drugs Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Evoke Pharma Gastroparesis Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.6 Teva Pharmaceutical Industries
  2.6.1 Business Overview
  2.6.2 Gastroparesis Drugs Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Teva Pharmaceutical Industries Gastroparesis Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.7 Theravance Biopharma
  2.7.1 Business Overview
  2.7.2 Gastroparesis Drugs Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 Theravance Biopharma Gastroparesis Drugs Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL GASTROPARESIS DRUGS MARKET COMPETITION, BY PLAYERS

3.1 Global Gastroparesis Drugs Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Gastroparesis Drugs Players Market Share
  3.2.2 Top 10 Gastroparesis Drugs Players Market Share
3.3 Market Competition Trend

4 GLOBAL GASTROPARESIS DRUGS MARKET SIZE BY REGIONS

4.1 Global Gastroparesis Drugs Revenue and Market Share by Regions
4.2 North America Gastroparesis Drugs Revenue and Growth Rate (2013-2018)
4.3 Europe Gastroparesis Drugs Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Gastroparesis Drugs Revenue and Growth Rate (2013-2018)
4.5 South America Gastroparesis Drugs Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Gastroparesis Drugs Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA GASTROPARESIS DRUGS REVENUE BY COUNTRIES

5.1 North America Gastroparesis Drugs Revenue by Countries (2013-2018)
5.2 USA Gastroparesis Drugs Revenue and Growth Rate (2013-2018)
5.3 Canada Gastroparesis Drugs Revenue and Growth Rate (2013-2018)
5.4 Mexico Gastroparesis Drugs Revenue and Growth Rate (2013-2018)

6 EUROPE GASTROPARESIS DRUGS REVENUE BY COUNTRIES

6.1 Europe Gastroparesis Drugs Revenue by Countries (2013-2018)
6.2 Germany Gastroparesis Drugs Revenue and Growth Rate (2013-2018)
6.3 UK Gastroparesis Drugs Revenue and Growth Rate (2013-2018)
6.4 France Gastroparesis Drugs Revenue and Growth Rate (2013-2018)
6.5 Russia Gastroparesis Drugs Revenue and Growth Rate (2013-2018)
6.6 Italy Gastroparesis Drugs Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC GASTROPARESIS DRUGS REVENUE BY COUNTRIES

7.1 Asia-Pacific Gastroparesis Drugs Revenue by Countries (2013-2018)
7.2 China Gastroparesis Drugs Revenue and Growth Rate (2013-2018)
7.3 Japan Gastroparesis Drugs Revenue and Growth Rate (2013-2018)
7.4 Korea Gastroparesis Drugs Revenue and Growth Rate (2013-2018)
7.5 India Gastroparesis Drugs Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Gastroparesis Drugs Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA GASTROPARESIS DRUGS REVENUE BY COUNTRIES

8.1 South America Gastroparesis Drugs Revenue by Countries (2013-2018)
8.2 Brazil Gastroparesis Drugs Revenue and Growth Rate (2013-2018)
8.3 Argentina Gastroparesis Drugs Revenue and Growth Rate (2013-2018)
8.4 Colombia Gastroparesis Drugs Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE GASTROPARESIS DRUGS BY COUNTRIES

9.1 Middle East and Africa Gastroparesis Drugs Revenue by Countries (2013-2018)
9.2 Saudi Arabia Gastroparesis Drugs Revenue and Growth Rate (2013-2018)
9.3 UAE Gastroparesis Drugs Revenue and Growth Rate (2013-2018)
9.4 Egypt Gastroparesis Drugs Revenue and Growth Rate (2013-2018)
9.5 Nigeria Gastroparesis Drugs Revenue and Growth Rate (2013-2018)
9.6 South Africa Gastroparesis Drugs Revenue and Growth Rate (2013-2018)

10 GLOBAL GASTROPARESIS DRUGS MARKET SEGMENT BY TYPE

10.1 Global Gastroparesis Drugs Revenue and Market Share by Type (2013-2018)
10.2 Global Gastroparesis Drugs Market Forecast by Type (2018-2023)
10.3 Prokinetic Agents Revenue Growth Rate (2013-2023)
10.4 Antiemetic Agents Revenue Growth Rate (2013-2023)
10.5 Botulinum Toxin Injection Revenue Growth Rate (2013-2023)
10.6 Other Revenue Growth Rate (2013-2023)

11 GLOBAL GASTROPARESIS DRUGS MARKET SEGMENT BY APPLICATION

11.1 Global Gastroparesis Drugs Revenue Market Share by Application (2013-2018)
11.2 Gastroparesis Drugs Market Forecast by Application (2018-2023)
11.3 Diabetic Gastroparesis Revenue Growth (2013-2018)
11.4 Idiopathic Gastroparesis Revenue Growth (2013-2018)

12 GLOBAL GASTROPARESIS DRUGS MARKET SIZE FORECAST (2018-2023)

12.1 Global Gastroparesis Drugs Market Size Forecast (2018-2023)
12.2 Global Gastroparesis Drugs Market Forecast by Regions (2018-2023)
12.3 North America Gastroparesis Drugs Revenue Market Forecast (2018-2023)
12.4 Europe Gastroparesis Drugs Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Gastroparesis Drugs Revenue Market Forecast (2018-2023)
12.6 South America Gastroparesis Drugs Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Gastroparesis Drugs Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Gastroparesis Drugs Picture
Table Product Specifications of Gastroparesis Drugs
Table Global Gastroparesis Drugs and Revenue (Million USD) Market Split by Product Type
Figure Global Gastroparesis Drugs Revenue Market Share by Types in 2017
Figure Prokinetic Agents Picture
Figure Antiemetic Agents Picture
Figure Botulinum Toxin Injection Picture
Figure Other Picture
Table Global Gastroparesis Drugs Revenue (Million USD) by Application (2013-2023)
Figure Gastroparesis Drugs Revenue Market Share by Applications in 2017
Figure Diabetic Gastroparesis Picture
Figure Idiopathic Gastroparesis Picture
Table Global Market Gastroparesis Drugs Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Gastroparesis Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Gastroparesis Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Gastroparesis Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Gastroparesis Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Gastroparesis Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Gastroparesis Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Table Cadila Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Cadila Pharmaceuticals Gastroparesis Drugs Type and Applications
Table Cadila Pharmaceuticals Gastroparesis Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Gastroparesis Drugs Type and Applications
Table GlaxoSmithKline Gastroparesis Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Gastroparesis Drugs Type and Applications
Table Johnson & Johnson Gastroparesis Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Valeant Basic Information, Manufacturing Base and Competitors
Table Valeant Gastroparesis Drugs Type and Applications
Table Valeant Gastroparesis Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Evoke Pharma Basic Information, Manufacturing Base and Competitors
Table Evoke Pharma Gastroparesis Drugs Type and Applications
Table Evoke Pharma Gastroparesis Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table Teva Pharmaceutical Industries Gastroparesis Drugs Type and Applications
Table Teva Pharmaceutical Industries Gastroparesis Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Theravance Biopharma Basic Information, Manufacturing Base and Competitors
Table Theravance Biopharma Gastroparesis Drugs Type and Applications
Table Theravance Biopharma Gastroparesis Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Global Gastroparesis Drugs Revenue (Million USD) by Players (2013-2018)
Table Global Gastroparesis Drugs Revenue Share by Players (2013-2018)
Figure Global Gastroparesis Drugs Revenue Share by Players in 2016
Figure Global Gastroparesis Drugs Revenue Share by Players in 2017
Figure Global Top 5 Players Gastroparesis Drugs Revenue Market Share in 2017
Figure Global Top 10 Players Gastroparesis Drugs Revenue Market Share in 2017
Figure Global Gastroparesis Drugs Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Gastroparesis Drugs Revenue (Million USD) by Regions (2013-2018)
Table Global Gastroparesis Drugs Revenue Market Share by Regions (2013-2018)
Figure Global Gastroparesis Drugs Revenue Market Share by Regions (2013-2018)
Figure Global Gastroparesis Drugs Revenue Market Share by Regions in 2017
Figure North America Gastroparesis Drugs Revenue and Growth Rate (2013-2018)
Figure Europe Gastroparesis Drugs Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Gastroparesis Drugs Revenue and Growth Rate (2013-2018)
Figure South America Gastroparesis Drugs Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Gastroparesis Drugs Revenue and Growth Rate (2013-2018)
Table North America Gastroparesis Drugs Revenue by Countries (2013-2018)
Table North America Gastroparesis Drugs Revenue Market Share by Countries (2013-2018)
Figure North America Gastroparesis Drugs Revenue Market Share by Countries (2013-2018)
Figure North America Gastroparesis Drugs Revenue Market Share by Countries in 2017
Figure USA Gastroparesis Drugs Revenue and Growth Rate (2013-2018)
Figure Canada Gastroparesis Drugs Revenue and Growth Rate (2013-2018)
Figure Mexico Gastroparesis Drugs Revenue and Growth Rate (2013-2018)
Table Europe Gastroparesis Drugs Revenue (Million USD) by Countries (2013-2018)
Figure Europe Gastroparesis Drugs Revenue Market Share by Countries (2013-2018)
Figure Europe Gastroparesis Drugs Revenue Market Share by Countries in 2017
Figure Germany Gastroparesis Drugs Revenue and Growth Rate (2013-2018)
Figure UK Gastroparesis Drugs Revenue and Growth Rate (2013-2018)
Figure France Gastroparesis Drugs Revenue and Growth Rate (2013-2018)
Figure Russia Gastroparesis Drugs Revenue and Growth Rate (2013-2018)
Figure Italy Gastroparesis Drugs Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Gastroparesis Drugs Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Gastroparesis Drugs Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Gastroparesis Drugs Revenue Market Share by Countries in 2017
Figure China Gastroparesis Drugs Revenue and Growth Rate (2013-2018)
Figure Japan Gastroparesis Drugs Revenue and Growth Rate (2013-2018)
Figure Korea Gastroparesis Drugs Revenue and Growth Rate (2013-2018)
Figure India Gastroparesis Drugs Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Gastroparesis Drugs Revenue and Growth Rate (2013-2018)
Table South America Gastroparesis Drugs Revenue by Countries (2013-2018)
Table South America Gastroparesis Drugs Revenue Market Share by Countries (2013-2018)
Figure South America Gastroparesis Drugs Revenue Market Share by Countries (2013-2018)
Figure South America Gastroparesis Drugs Revenue Market Share by Countries in 2017
Figure Brazil Gastroparesis Drugs Revenue and Growth Rate (2013-2018)
Figure Argentina Gastroparesis Drugs Revenue and Growth Rate (2013-2018)
Figure Colombia Gastroparesis Drugs Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Gastroparesis Drugs Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Gastroparesis Drugs Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Gastroparesis Drugs Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Gastroparesis Drugs Revenue Market Share by Countries in 2017
Figure Saudi Arabia Gastroparesis Drugs Revenue and Growth Rate (2013-2018)
Figure UAE Gastroparesis Drugs Revenue and Growth Rate (2013-2018)
Figure Egypt Gastroparesis Drugs Revenue and Growth Rate (2013-2018)
Figure Nigeria Gastroparesis Drugs Revenue and Growth Rate (2013-2018)
Figure South Africa Gastroparesis Drugs Revenue and Growth Rate (2013-2018)
Table Global Gastroparesis Drugs Revenue (Million USD) by Type (2013-2018)
Table Global Gastroparesis Drugs Revenue Share by Type (2013-2018)
Figure Global Gastroparesis Drugs Revenue Share by Type (2013-2018)
Figure Global Gastroparesis Drugs Revenue Share by Type in 2017
Table Global Gastroparesis Drugs Revenue Forecast by Type (2018-2023)
Figure Global Gastroparesis Drugs Market Share Forecast by Type (2018-2023)
Figure Global Prokinetic Agents Revenue Growth Rate (2013-2018)
Figure Global Antiemetic Agents Revenue Growth Rate (2013-2018)
Figure Global Botulinum Toxin Injection Revenue Growth Rate (2013-2018)
Figure Global Other Revenue Growth Rate (2013-2018)
Table Global Gastroparesis Drugs Revenue by Application (2013-2018)
Table Global Gastroparesis Drugs Revenue Share by Application (2013-2018)
Figure Global Gastroparesis Drugs Revenue Share by Application (2013-2018)
Figure Global Gastroparesis Drugs Revenue Share by Application in 2017
Table Global Gastroparesis Drugs Revenue Forecast by Application (2018-2023)
Figure Global Gastroparesis Drugs Market Share Forecast by Application (2018-2023)
Figure Global Diabetic Gastroparesis Revenue Growth Rate (2013-2018)
Figure Global Idiopathic Gastroparesis Revenue Growth Rate (2013-2018)
Figure Global Gastroparesis Drugs Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Gastroparesis Drugs Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Gastroparesis Drugs Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Gastroparesis Drugs Revenue Market Forecast (2018-2023)
Figure Europe Gastroparesis Drugs Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Gastroparesis Drugs Revenue Market Forecast (2018-2023)
Figure South America Gastroparesis Drugs Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Gastroparesis Drugs Revenue Market Forecast (2018-2023)